前沿生物：拟向激励对象27人授予限制性股票500万股

Group 1 - The company, Qianyan Bio, announced an incentive plan involving 27 individuals, with a total of 5 million restricted shares to be granted, representing approximately 1.33% of the company's total share capital of about 375 million shares [1] - The grant price for the restricted shares is set at 8.56 yuan per share, with a validity period of up to 36 months from the date of grant [1] - For the year 2024, the company's revenue composition is projected to be 97.13% from the pharmaceutical manufacturing industry and 2.87% from other businesses [1] Group 2 - As of the latest report, the market capitalization of Qianyan Bio is 5.6 billion yuan [2]